In this article, Matt Cooper and Scott Palmese discuss the pivotal role site networks play in aligning sponsors, sites, and investigators toward shared goals in oncology clinical trials. However, they are not one-size-fits-all. Sponsors must carefully vet site networks to validate that they will deliver strategic value for each individual study. Read the full article here.
Matt Cooper, PhD, Executive Director, Therapeutic Strategy Lead, Oncology
Scott Palmese, Executive Director, Site Relationships and Patient Pathways
